1.
Biopharm International
; 36(4), 2023.
Article
in English
| Web of Science | ID: covidwho-2328072
2.
BioPharm International
; 36(4):15-17, 2023.
Article
in English
| EMBASE | ID: covidwho-2317268
3.
BioPharm International
; 35(2):26-29, 2022.
Article
in English
| Scopus | ID: covidwho-2012042
4.
BioPharm Int.
; 35:40-41, 2022.
Article
in English
| EMBASE | ID: covidwho-1913121
5.
BioPharm International
; 35(1):26-29, 2022.
Article
in English
| Scopus | ID: covidwho-1905030
6.
Biopharm International
; 34(12):42-44, 2021.
Article
in English
| Web of Science | ID: covidwho-1663213
7.
Biopharm International
; 34(2):40-43, 2021.
Article
in English
| Web of Science | ID: covidwho-1535603
ABSTRACT
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
8.
Pharmaceutical Technology
; 45(6):14-19, 2021.
Article
in English
| EMBASE | ID: covidwho-1525165
9.
Pharmaceutical Technology
; 2021:S22-S23, 2021.
Article
in English
| Scopus | ID: covidwho-1208082
10.
Pharmaceutical Technology
; 44(11):50-52, 2020.
Article
in English
| Scopus | ID: covidwho-1130145
11.
BioPharm International
; 33(10):31-36, 2020.
Article
in English
| Scopus | ID: covidwho-884342